Keyword Analysis & Research: niosh hazardous drug list
Keyword Research: People who searched niosh hazardous drug list also searched
Search Results related to niosh hazardous drug list on Search Engine
-
NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare …
https://www.cdc.gov/niosh/docs/2016-161/default.html
webNIOSH list of hazardous drugs; Drug AHFS Classification Links Date Approved; trabectedin (Yondelis ®) 10:00 Antineoplastic Agents: DailyMed: October 23, 2015: inotuzumab ozogamicin (Besponsa™) 10:00 Antineoplastic Agents: DailyMed: August 17, 2017: polatuzumab vedotin (Polivy™) 10:00 Antineoplastic Agents: DailyMed: June 10, 2019 ...
DA: 79 PA: 22 MOZ Rank: 26
-
NIOSH List of Antineoplastic and Other Hazardous Drugs …
https://www.cdc.gov/niosh/docs/2016-161/pdfs/2016-161.pdf
webThe 2004 list was updated in 2010, 2012, and 2014. The current update (2016) adds 34 drugs, five of which have safe-handling rec-ommendations from the manufacturers. In 2014, a new format was developed for the list of hazardous drugs, as described below.
DA: 82 PA: 37 MOZ Rank: 65
-
Hazardous Drug Exposures in Health Care | NIOSH | CDC
https://www.cdc.gov/niosh/topics/hazdrug/default.html
webNIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016 DHHS (NIOSH) Publication Number 2016-161. Managing Hazardous Drug Exposures: Information for Healthcare Settings DHHS (NIOSH) Publication Number 2023-130 (April 2023)
DA: 100 PA: 40 MOZ Rank: 67
-
Hazardous Drugs: Draft NIOSH List of Hazardous Drugs in …
https://www.federalregister.gov/documents/2020/05/01/2020-09332/hazardous-drugs-draft-niosh-list-of-hazardous-drugs-in-healthcare-settings-2020-procedures-and-risk
webMay 1, 2020 · Hazardous Drugs: Draft NIOSH List of Hazardous Drugs in Healthcare Settings, 2020; Procedures; and Risk Management Information. A Notice by the Centers for Disease Control and Prevention on 05/01/2020. Published Document. AGENCY: Centers for Disease Control and Prevention, HHS. ACTION: Notice and request for comment. SUMMARY:
DA: 49 PA: 17 MOZ Rank: 56
-
NIOSH Finalizes Procedures for Developing Hazardous Drug List
https://news.ashp.org/News/ashp-news/2023/04/27/niosh-finalizes-procedures-for-developing-hazardous-drug-list
webPublished: April 27, 2023. The Centers for Disease Control and Prevention National Institute for Occupational Safety and Health (NIOSH) has published final versions of two documents: Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings and Managing Hazardous Drug Exposures: Information for Healthcare Settings.
DA: 74 PA: 57 MOZ Rank: 30
-
NIOSH Updates List of Hazardous Drugs in Healthcare Settings …
https://www.aiha.org/news/niosh-updates-list-of-hazardous-drugs-in-healthcare-settings-for-2020
webMay 7, 2020 · Five drugs have been removed. The agency has also retitled and reorganized the document. The new name for the list, the NIOSH List of Hazardous Drugs in Healthcare Settings, updates the previous title, the NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings.
DA: 85 PA: 91 MOZ Rank: 99
-
New NIOSH Documents Address Hazardous Drugs in Healthcare …
https://www.aiha.org/news/230427-new-niosh-documents-address-hazardous-drugs-in-healthcare-settings
webApr 27, 2023 · NIOSH announced the retitling of the list in 2020, explaining in the Federal Register that “ [m]any of the drugs currently used to fight cancer function differently than those previously used” and that “antineoplastic drugs are no longer all cytotoxic, genotoxic, and highly hazardous chemicals.”
DA: 11 PA: 5 MOZ Rank: 25
-
Hazardous Drug Exposures in Health Care | NIOSH | CDC
http://medbox.iiab.me/modules/en-cdc/www.cdc.gov/niosh/topics/hazdrug/default.html/
webHealth care workers who prepare or administer hazardous drugs (e.g., those used for cancer therapy, and some antiviral drugs, hormone agents, and bioengineered drugs) or who work in areas where these drugs are used may be exposed to these agents in the workplace.
DA: 48 PA: 46 MOZ Rank: 51
-
NIOSH List of Antineoplastic and Other Hazardous Drugs in …
https://downloads.regulations.gov/CDC-2018-0004-0019/content.pdf
webFor each drug, the comments received are organized by the categories in the NIOSH Hazardous Drug definition: carcinogenicity, genotoxicity, organ toxicity at low dose, reproductive toxicity, and teratogenicity or other developmental toxicity as defined in the Policy and Procedures.
DA: 28 PA: 16 MOZ Rank: 80
-
NIOSH List of Antineoplastic and Other Hazardous Drugs …
https://downloads.regulations.gov/CDC-2018-0004-0064/content.pdf
webFor each drug, the comments received are organized by the categories in the NIOSH Hazardous Drug definition: carcinogenicity, genotoxicity, organ toxicity at low dose, reproductive toxicity, and teratogenicity or other developmental toxicity as defined in the Policy and Procedures.
DA: 92 PA: 42 MOZ Rank: 55